Description
The treatment (2 x 5 min. daily) resulted in a significant volume reduction of the prostate after only 28 days of therapy (V1) compared to the start of treatment (V0). The sustainability of the therapy effect is shown by the fact that after only 4 months (V2) a significant volume reduction of the prostate gland was observed compared to the start of treatment (V0). Also in the survey on quality of life (IPSS questionnaire: urination/quality of life), significantly better results were achieved at both points in time (V1 and V2) than with V0. Overall, there was a rapid improvement in symptoms without changes in gonadal hormones or sexual function, with high compliance and without side effects. The best results were achieved in patients with moderate to severe symptoms (LUTS) and patients without metabolic syndrome (MetS).
